Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.03.2022 | Case report

Multiple drugs

Various toxicities and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Yu T-Y, et al. A case of refractory T-cell lymphoblastic lymphoma coexisting with ZMYM2-fibroblastic growth factor receptor-1 fusion-related myeloproliferative disease and review of literatures. Journal of Medical Sciences 42: 50-52, No. 1, 2022. Available from: URL: http://www.jmedscindmc.com/ Yu T-Y, et al. A case of refractory T-cell lymphoblastic lymphoma coexisting with ZMYM2-fibroblastic growth factor receptor-1 fusion-related myeloproliferative disease and review of literatures. Journal of Medical Sciences 42: 50-52, No. 1, 2022. Available from: URL: http://​www.​jmedscindmc.​com/​
Metadaten
Titel
Multiple drugs
Various toxicities and lack of efficacy: case report
Publikationsdatum
01.03.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-12257-y

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Multiple drugs

Case report

Bcg/ethambutol